Northern Oak Wealth Management Inc Gilead Sciences, Inc. Transaction History

Northern Oak Wealth Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$57.72 - $65.01 $15,873 - $17,877	-275 Reduced 20.0%	1,100 $68,000
Q2 2021 Aug 17, 2021	SELL	$63.47 - $69.35 $145,028 - $158,464	-2,285 Reduced 62.43%	1,375 $95,000
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $137,100 - $156,431	2,285 Added 166.18%	3,660 $237,000
Q2 2020 Aug 17, 2020	SELL	$72.34 - $84.0 $36,170 - $42,000	-500 Reduced 26.67%	1,375 $106,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $17,223 - $22,060	275 Added 17.19%	1,875 $140,000
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $61,620 - $67,780	1,000 Added 166.67%	1,600 $103,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $8,126 - $8,970	-130 Reduced 17.81%	600 $38,000
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $8,043 - $9,019	130 Added 21.67%	730 $0
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $7,264 - $9,480	-120 Reduced 16.67%	600 $37,000
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $7,866 - $9,590	-108 Reduced 13.04%	720 $0
Q4 2017 Feb 16, 2018	BUY	$71.15 - $83.52 $58,912 - $69,154	828	828 $0

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Northern Oak Wealth Management Inc, based on Form 13F filings with the SEC.

Stay updated on Northern Oak Wealth Management Inc with notifications on news.